OBIO Member, Focal Healthcare Inc, has been granted a Class II Health Canada Medical Device License for its targeted prostate biopsy device, Fusion Bx. Fusion Bx uses MRI/Ultrasound fusion to provide urologists with 3D image-guidance, allowing biopsies to be taken directly from suspicious cancer regions in the prostate for improved prostate cancer diagnosis.
Click HERE to read the full press release